KZIA
Kazia Therapeutics Ltd Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website kaziatherapeutics.com
- Employees(FY) -
- ISIN US48669G1058
Performance
-13.62%
1W
-20.51%
1M
+9.46%
3M
-57.14%
6M
-34.2%
YTD
-76.53%
1Y
Profile
Kazia Therapeutics Limited operates as a biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway, which is developed as a potential therapy for glioblastoma, diffuse intrinsic pontine glioma/advanced solid tumors, atypical teratoid rhabdoid tumor, brain metastases, triple negative breast cancer, and primary central nervous system lymphoma. It is also developing EVT801, a small molecule targeted therapeutic vascular endothelial growth factor receptor 3 inhibitor. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. The company was incorporated in 1994 and is based in Sydney, Australia.
Technical Analysis of KZIA 2024-05-03
Overview:
In analyzing the technical indicators for KZIA over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer insights into the possible future direction of KZIA's stock price.
...Recent News & Updates
- 2024-05-01 16:22
- 2024-04-30 20:45
- 2024-03-23 19:55
11 Best ASX Stocks To Buy Now(Insidermonkey)
- 2024-03-20 20:52
- 2024-03-12 20:00
- 2024-02-20 18:30
- 2024-01-17 18:30
- 2023-12-05 05:02
- 2023-11-30 19:00
- 2023-11-28 18:01
- 2023-11-20 18:30
- 2023-11-20 03:30
- 2023-11-14 19:30
- 2023-11-09 18:01
- 2023-10-31 19:01
- 2023-10-22 19:01
- 2023-10-10 19:01
Kazia announces voluntary delisting from ASX(Prnewswire)
- 2023-10-04 19:01
- 2023-09-28 19:01
- 2023-07-05 19:00
- 2023-06-07 19:00
- 2023-05-24 19:01
- 2023-04-13 19:01
- 2023-04-03 19:00
- 2023-01-25 02:03
- 2023-01-17 22:50
Kazia Therapeutics CEO talks $4.5 million capital raise(Yahoo Finance)
- 2023-01-15 18:01
KAZIA RAISES A$4.5 MILLION TO PROGRESS R&D PROGRAMS(Yahoo Finance)
- 2022-12-19 08:00
- 2022-12-14 18:01
- 2022-12-11 18:01
KAZIA ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID NOTIFICATION(Yahoo Finance)
Page 1 of 4
previousnext